Valuation: Stem Cells Spin S.A.

Market Cap	16.53M 4.37M 3.83M 3.54M 3.27M 6.2M 419M 6.32M 42.55M 205M 16.42M 16.06M 711M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	16.62M 4.39M 3.85M 3.56M 3.29M 6.23M 421M 6.36M 42.77M 206M 16.5M 16.14M 715M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-15	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-13	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-13	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-13	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-13	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
24-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
24-02-14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
23-11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	2016-12-31

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	2022-06-27
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	2022-03-14

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	-0.50%	0.00%	+72.41%	+1.01%	4.37M
LONZA GROUP AG	+0.16%	+1.66%	+2.03%	+8.59%	49.42B
REVOLUTION MEDICINES, INC.	-0.36%	+1.21%	+420.77%	+619.10%	40.34B
IQVIA HOLDINGS INC.	-2.13%	+0.29%	+23.91%	-6.01%	34.01B
BEONE MEDICINES AG	-2.29%	+3.83%	+23.48%	+59.26%	33.56B
CELLTRION, INC.	-0.79%	+1.32%	+5.78%	+36.42%	26.84B
ASCENDIS PHARMA A/S	+3.82%	+3.51%	-	-	17.22B
MEDPACE HOLDINGS, INC.	-2.62%	-2.13%	+64.96%	+125.87%	15.19B
IONIS PHARMACEUTICALS, INC.	-2.17%	+6.65%	+104.31%	+102.15%	13.96B
EUROFINS SCIENTIFIC SE	-0.48%	-3.44%	+11.83%	+17.25%	13.36B
Average	-0.73%	+1.33%	+81.05%	+107.07%	24.39B
Weighted average by Cap.	-0.77%	+1.54%	+94.55%	+139.98%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-13 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
26-07-08	PLN 0.4000	-0.50%	100
26-07-07	PLN 0.4020	+0.50%	5,027
26-07-06	PLN 0.4000	0.00%	100
26-07-02	PLN 0.4000	0.00%	16,104
26-07-01	PLN 0.4000	0.00%	200

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 2026-07-08			5-day change	1st Jan Change
0.4000 ^PLN	-0.50%		0.00%	-1.48%

1 day	-0.50%
1 month	+2.56%
3 months	+11.11%
6 months	-2.91%
Current year	-1.48%

1 week	0.4	0.4
1 month	0.37	0.44
Current year	0.33	0.48
1 year	0.26	0.52
3 years	0.14	0.82
5 years	0.14	1.23
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.35K 12.59K 11.62K 10.74K 20.35K 1.37M 20.76K 140K 672K 53.89K 52.71K 2.33M	65.74K 17.38K 15.24K 14.07K 13K 24.65K 1.66M 25.14K 169K 814K 65.27K 63.83K 2.83M
Net income	-520K -138K -121K -111K -103K -195K -13.17M -199K -1.34M -6.45M -517K -505K -22.37M	-526K -139K -122K -113K -104K -197K -13.31M -201K -1.35M -6.51M -522K -510K -22.6M
Net Debt	69.28K 18.32K 16.07K 14.83K 13.71K 25.98K 1.75M 26.5K 178K 858K 68.79K 67.28K 2.98M	84.58K 22.36K 19.61K 18.11K 16.73K 31.72K 2.14M 32.35K 218K 1.05M 83.98K 82.14K 3.64M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates